Hugel Aesthetics

Hugel Aesthetics is a division of Hugel, Inc., a global leader in medical aesthetics. Hugel Aesthetics plans to accelerate its global expansion by offering a complete portfolio of aesthetic products to the United States, Canada, and Australia. Our injectable Lidocaine (LetibotulinumtoxinA) for the treatment of glabellar lines is currently under review in the United States and Australia. It is already available in 28 countries worldwide and has recently received approval in Europe and Canada. Hugel Aesthetics is committed to making aesthetic opportunities more accessible to everyone.